(Reuters) – British fund manager Neil Woodford is looking to kick off the sale of his unlisted biotech investments at the end of July, but faces months of negotiations to offload the portfolio, a source familiar with the matter told Reuters.
Woodford biotech stakes first off block in asset sale
This entry was posted in Syndicated. Bookmark the permalink.
